ENVESTNET ASSET MANAGEMENT INC

Position in ZYME — Zymeworks Inc.

CIK 1407543 Berwyn, PA

Position in ZYME

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$1,012,091

-$62,488 QoQ

Shares Held

40,419

-1.0% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. ZYME ranks #54 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	503,564	$224,861,468
2	REGN	Regeneron Pharmaceuticals, Inc.	109,152	$84,335,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	171,797	$56,842,473
4	INSM	INSMED Inc	299,925	$49,043,736
5	ARGX	Argenx SE	61,418	$44,850,494
6	RPRX	Royalty Pharma plc	495,892	$23,787,939
7	GMAB	Genmab A/S	862,301	$23,135,535
8	ROIV	Roivant Sciences Ltd.	678,518	$18,794,948

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,012,091	40,419	-1.0%	Shares	Sole	2026-05-04
2025-12-31	$1,074,579	40,812	+180.0%	Shares	Sole	2026-02-10
2025-09-30	$248,923	14,574	-0.2%	Shares	Sole	2025-11-05
2025-06-30	$183,305	14,606	-70.5%	Shares	Sole	2025-08-01
2025-03-31	$589,687	49,512	-8.5%	Shares	Sole	2025-04-29
2024-12-31	$791,877	54,090	-17.6%	Shares	Sole	2025-02-13
2024-09-30	$824,258	65,678	+4.8%	Shares	Sole	2024-11-07
2024-06-30	$533,440	62,684	-4.9%	Shares	Sole	2024-08-08
2024-03-31	$693,362	65,909	+32.5%	Shares	Sole	2024-05-13
2023-12-31	$517,006	49,760	+19.3%	Shares	Sole	2024-02-13
2023-09-30	$264,339	41,694	+43.7%	Shares	Sole	2023-11-13
2023-06-30	$250,603	29,005	+12.9%	Shares	Sole	2023-08-04
2023-03-31	$232,174	25,683	-54.3%	Shares	Sole	2023-05-11
2022-12-31	$441,456	56,165	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.